內險股漲跌不一 眾安在線、中國財險領漲
格隆匯10月15日丨港股市場內險股漲跌不一,但眾安在線(6060.HK)和中國財險(2328.HK)有明顯上漲,目前漲幅均逼近4%,中國人壽和中國人民保險微漲。眾安在線目前公佈,今年前9個月所獲得的原保險保費收入總額約為99.35億元,按年上升21.5%,去年同期收入為81.79億元。中國財險獲大和升評級至“買入” ,目標價上調至11.5港元。大和發表報告,認為中國財險(2328.HK)的盈利能力已過最壞時刻,相信其綜合營運比率將自今年下半年起反彈,其中車險分部長達四年錄得綜合營運比率下降的趨勢將迎來尾聲。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.